AR007814A1 - Un compuesto derivado de benzo[g]quinolina, uso del mismo, un proceso para prepararlo y una composicion farmaceutica que lo comprende. - Google Patents
Un compuesto derivado de benzo[g]quinolina, uso del mismo, un proceso para prepararlo y una composicion farmaceutica que lo comprende.Info
- Publication number
- AR007814A1 AR007814A1 ARP970103017A ARP970103017A AR007814A1 AR 007814 A1 AR007814 A1 AR 007814A1 AR P970103017 A ARP970103017 A AR P970103017A AR P970103017 A ARP970103017 A AR P970103017A AR 007814 A1 AR007814 A1 AR 007814A1
- Authority
- AR
- Argentina
- Prior art keywords
- benzo
- quinoline
- pharmaceutical composition
- understands
- prepare
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/10—Ophthalmic agents for accommodation disorders, e.g. myopia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Ophthalmology & Optometry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Abstract
Se refiere a un compuesto derivado de benzo [g]quinolina que tiene la fórmula I en la que A y B son cada uno H o forman juntos un enlace adicional,X es CH2, o CO, Y es O, S, S-O, NR2, [R2, es H o alquilo de C2-C4, CH3 o o bien O-CH3, yR es de la fórmula (a), (b), (c), (d), (e), (f), (g), (h) e(i) en donde R2 es H o trifluorometilo, Z1 es O, S o NH y Z2 es CH o N, con la condición de que si X es CH2, Y es S y R es de la fórmula (a) en la que elenlace libre está adyacente alnit rógeno y R2 es H, entonces A y B no son H, en forma de sal de adición de base o de ácido libre. Se refiere además a losusos de dicho compuesto, a un proceso para prepararlo y a una composición farmacéutica que lo comprende.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9614282.3A GB9614282D0 (en) | 1996-07-08 | 1996-07-08 | Organic compounds |
| GBGB9626093.0A GB9626093D0 (en) | 1996-12-16 | 1996-12-16 | Organic compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR007814A1 true AR007814A1 (es) | 1999-11-24 |
Family
ID=26309658
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP970103017A AR007814A1 (es) | 1996-07-08 | 1997-07-07 | Un compuesto derivado de benzo[g]quinolina, uso del mismo, un proceso para prepararlo y una composicion farmaceutica que lo comprende. |
Country Status (28)
| Country | Link |
|---|---|
| US (1) | US6057334A (es) |
| EP (1) | EP0912553B1 (es) |
| JP (1) | JP4216337B2 (es) |
| KR (1) | KR100491478B1 (es) |
| CN (1) | CN1125065C (es) |
| AR (1) | AR007814A1 (es) |
| AT (1) | ATE211470T1 (es) |
| AU (1) | AU719119B2 (es) |
| BR (1) | BR9710218A (es) |
| CA (1) | CA2257646C (es) |
| CO (1) | CO4870760A1 (es) |
| CY (1) | CY2322B1 (es) |
| CZ (1) | CZ2799A3 (es) |
| DE (1) | DE69709869T2 (es) |
| DK (1) | DK0912553T3 (es) |
| ES (1) | ES2170402T3 (es) |
| HK (1) | HK1020569A1 (es) |
| ID (1) | ID18896A (es) |
| IL (1) | IL127376A (es) |
| NO (1) | NO319401B1 (es) |
| NZ (1) | NZ333311A (es) |
| PE (1) | PE87998A1 (es) |
| PL (1) | PL330723A1 (es) |
| PT (1) | PT912553E (es) |
| SK (1) | SK399A3 (es) |
| TR (1) | TR199900016T2 (es) |
| TW (1) | TW378209B (es) |
| WO (1) | WO1998001444A1 (es) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PE20030240A1 (es) * | 2001-07-09 | 2003-04-16 | Novartis Ag | DERIVADOS DE BENZO [g] QUINOLINA |
| EG24415A (en) | 2002-03-07 | 2009-05-25 | Novartis Ag | Quinoline derivatives |
| SI1757601T1 (sl) * | 2002-03-07 | 2009-12-31 | Novartis Ag | Kinolinski derivati in njihova uporaba pri glavkomu in miopiji |
| US20070093507A1 (en) * | 2003-09-05 | 2007-04-26 | Lambrou George N | Compositions comprising benzo (g) quinoline derivatives and prostaglandin derivatives |
| CN105434439B (zh) * | 2015-11-11 | 2018-07-24 | 温州医科大学 | 一种多巴胺d2受体的部分激动剂在制备抑制近视药物上的应用及其使用方法 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19575006I2 (de) * | 1981-10-16 | 2003-01-09 | Novartis Ag | 1, 2, 3, 4a, 5, 10, 10a-Octahydrobenzo(g)chinolin-Derivate mit pharmazeutischer Wirkung |
| AU3879789A (en) * | 1988-07-22 | 1990-02-19 | Sandoz Ag | Use of benzo(g)quinolines in treatment of nicotine addiction |
| GB8829330D0 (en) * | 1988-12-16 | 1989-02-01 | Sandoz Ltd | Improvements in or relating to organic compounds |
| US5262422A (en) * | 1991-05-02 | 1993-11-16 | Sandoz Ltd. | Octahydrobenzo[g]quinoline |
| DE4114325A1 (de) * | 1991-05-02 | 1992-11-05 | Sandoz Ag | Octahydrobenzo(g)chinolin, seine herstellung und verwendung |
| GB9326010D0 (en) * | 1993-12-21 | 1994-02-23 | Sandoz Ltd | Improvements in or relating to organic compounds |
| FR2729145A1 (fr) * | 1995-01-06 | 1996-07-12 | Smithkline Beecham Lab | Nouveaux derives d'amine, leur procede de preparation et leur utilisation en tant que medicaments et notamment en tant qu'agents anti-arythmiques |
-
1997
- 1997-06-16 TW TW086108396A patent/TW378209B/zh not_active IP Right Cessation
- 1997-07-07 PT PT97931793T patent/PT912553E/pt unknown
- 1997-07-07 CA CA002257646A patent/CA2257646C/en not_active Expired - Fee Related
- 1997-07-07 CN CN97196208A patent/CN1125065C/zh not_active Expired - Fee Related
- 1997-07-07 KR KR10-1999-7000016A patent/KR100491478B1/ko not_active IP Right Cessation
- 1997-07-07 ID IDP972340A patent/ID18896A/id unknown
- 1997-07-07 SK SK3-99A patent/SK399A3/sk unknown
- 1997-07-07 CO CO97037766A patent/CO4870760A1/es unknown
- 1997-07-07 DK DK97931793T patent/DK0912553T3/da active
- 1997-07-07 US US09/214,537 patent/US6057334A/en not_active Expired - Lifetime
- 1997-07-07 ES ES97931793T patent/ES2170402T3/es not_active Expired - Lifetime
- 1997-07-07 PL PL97330723A patent/PL330723A1/xx unknown
- 1997-07-07 NZ NZ333311A patent/NZ333311A/en not_active IP Right Cessation
- 1997-07-07 AU AU35422/97A patent/AU719119B2/en not_active Ceased
- 1997-07-07 CZ CZ9927A patent/CZ2799A3/cs unknown
- 1997-07-07 WO PCT/EP1997/003582 patent/WO1998001444A1/en active IP Right Grant
- 1997-07-07 TR TR1999/00016T patent/TR199900016T2/xx unknown
- 1997-07-07 IL IL12737697A patent/IL127376A/xx not_active IP Right Cessation
- 1997-07-07 PE PE1997000585A patent/PE87998A1/es not_active Application Discontinuation
- 1997-07-07 JP JP50478898A patent/JP4216337B2/ja not_active Expired - Fee Related
- 1997-07-07 DE DE69709869T patent/DE69709869T2/de not_active Expired - Lifetime
- 1997-07-07 BR BR9710218A patent/BR9710218A/pt not_active IP Right Cessation
- 1997-07-07 AR ARP970103017A patent/AR007814A1/es active IP Right Grant
- 1997-07-07 AT AT97931793T patent/ATE211470T1/de active
- 1997-07-07 EP EP97931793A patent/EP0912553B1/en not_active Expired - Lifetime
-
1999
- 1999-01-05 NO NO19990035A patent/NO319401B1/no not_active IP Right Cessation
- 1999-11-02 HK HK99104973A patent/HK1020569A1/xx not_active IP Right Cessation
-
2003
- 2003-04-30 CY CY0300034A patent/CY2322B1/xx unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EA200200546A1 (ru) | Устойчивый полиморф гидрохлорида n-(3-этинилфенил)-6,7-бис(2-метоксиэтокси)-4-хиназолинамина, способы его получения и фармацевтические применения | |
| AR024634A1 (es) | Composicion farmaceutica estabilizada en forma liofilizada | |
| TR199901674T2 (es) | ||
| BR0014116A (pt) | Uso de um composto, composto, métodos para preparação de um composto, e para inibir aurora 2 quinase em um animal de sangue quente, e, composição farmacêutica | |
| AR031597A1 (es) | Compuestos piperidinos,un proceso para su preparacion, composiciones farmaceuticas,y el uso de dichos compuestos para la fabricacion de un medicamento para uso como inhibidores ccr-3 | |
| AR005706A1 (es) | Inhibidores egfr de 4-aminoquinzolina, procedimiento para su obtencion, composicion farmaceutica que los contiene, uso de los mismos para lapreparacion de un medicamento util como agente antineoplasico | |
| BR0212185A (pt) | Compostos e métodos para a preparação de compostos | |
| YU149791A (sh) | Mometason, furoat monohidrat i postupak za njegovo dobijanje | |
| ES2260933T3 (es) | Derivados del acido de tiazolina. | |
| DE3769676D1 (de) | Prodrugverbindungen, verfahren zu deren herstellung und diese enthaltende zubereitungen mit verzoegerter freisetzung. | |
| ES2039242T3 (es) | Un procedimiento para la preparacion de nuevos derivados de piperidina. | |
| BRPI0416080A (pt) | composto, uso do mesmo, complexo de metal de transição, e, processos para preparar o mesmo, para adicionar ácido cianìdrico a uma dupla ligação olefìnica, e para isomerizar nitrilas orgánicas na presença de um catalisador, e, uso de complexos de metal de transição | |
| BRPI0500590B8 (pt) | processo para a síntese de compostos de 1,3,4,5-tetraidro-2h-3-benzazepin-2-ona, e aplicação na síntese de ivabradina e sais de adição desta com um ácido farmaceuticamente aceitável | |
| BR9812808A (pt) | 3,6-hemicetais da classe de 9a-azalidas, processo para preparação dos mesmos, seuuso farmacêutico, bem como composição farmacêutica compreendendo os mesmos | |
| BR9914787A (pt) | Processo para a preparação de um composto | |
| CO4830475A1 (es) | Composicion lubricante | |
| MX9304399A (es) | Proceso novedoso para preparar [[2-bromoetil)-amino]metil]-2-nitro-1h-imidazol-1-etanol quiral y compuestos relacionados. | |
| AR007814A1 (es) | Un compuesto derivado de benzo[g]quinolina, uso del mismo, un proceso para prepararlo y una composicion farmaceutica que lo comprende. | |
| EA200000910A1 (ru) | Азабициклические лиганды рецепторов 5нт1 | |
| EA200301317A1 (ru) | Производные аминохинолина и его применение в качестве лигандов аденозина a3 | |
| ES2094812T3 (es) | Un procedimiento mejorado para la preparacion de derivados sustituidos de indolona. | |
| DE69529624D1 (de) | Neue endiyn-chinonimine und verfahren zu deren herstellung und verwendung | |
| HUP0004356A2 (hu) | Amin-oxidot és betainvegyületeket tartalmazó készítmény | |
| EA199800715A1 (ru) | Новые соединения цефема и их использование в качестве лекарственных препаратов | |
| BR9911145A (pt) | Composto, uso de um composto, composição farmacêutica, e, processo para tratamento de um mamìfero e para a preparação de compostos |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant, registration | ||
| FG | Grant, registration |